Results 1 to 10 of about 64,436 (205)

Efficacy of atropine, orthokeratology, and combined atropine with orthokeratology for childhood myopia: A systematic review and network meta-analysis

Journal of the Formosan Medical Association, 2022
Background/Purpose: Orthokeratology (Ortho-K), atropine eye drops and combined atropine with Ortho-K are proven to be effective ways to prevent myopic progression in many studies, but there is scarce evidence regarding the comparative efficacy of ...
Hou-Ren Tsai, Jen-Hung Wang, Huei-Kai Huang, Tai-Li Chen, Po-Wei Chen, Cheng-Jen Chiu   +5 more
doaj   +3 more sources

Electroanalytical overview: The detection of the molecule of murder atropine

Talanta Open, 2021
In this overview we explore the electroanalytical determination of the molecule of murder: atropine. Atropine, occurs naturally in various plants of the nightshade family, including the deadly nightshade (Atropa belladonna).
Robert D. Crapnell, Craig E. Banks
doaj   +3 more sources

STudy of Atropine to Reduce (STAR) Myopia Progression in Children: 24-Month Results of a Randomized, Double-Masked, Vehicle-Controlled Trial of Atropine Sulfate 0.01% and 0.03% [PDF]

Ophthalmology and Therapy
Introduction Pediatric myopia is rising globally, with high myopia associated with sight-threatening complications later in life. Low-dose atropine has been shown to slow myopia progression, with most studies conducted in Asian populations using ...
Michael Korenfeld, Maria Hurcikova, Kay Tatsuoka, Dana Tomciková, Janet Cheetham, Marek Kacerik, on behalf of the STAR Study Investigators   +6 more
doaj   +2 more sources

Network pharmacology and molecular dynamics simulations reveal shared mechanisms and myopia-specific targets of atropine in myopia and dry eye disease [PDF]

Eye and Vision
Background Atropine is an effective agent for myopia control; however, clinical reports have indicated potential side effects associated with inducing or exacerbating dry eye disease (DED).
Meng Lin, Wanyi Shu, Guo Hua, Zhikang Duan, Jia Qu, Liang Hu   +5 more
doaj   +2 more sources

A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/atropine.

PLoS ONE, 2023
PurposeTo evaluate the efficacy of a myopia control spectacle lens (DIMS) at slowing the progression of myopia in a population of European children in comparison with 0.01% atropine and combined DIMS and atropine.MethodsThe study was a non-randomised ...
Paolo Nucci, Andrea Lembo, Irene Schiavetti, Rakhee Shah, David Francis Edgar, Bruce John William Evans   +5 more
doaj   +5 more sources

The Effect of Low-Dose Atropine on Alpha Ganglion Cell Signaling in the Mouse Retina

Frontiers in Cellular Neuroscience, 2021
Low-dose atropine helps to control myopia progression with few side effects. However, the impact of atropine, a non-selective muscarinic Acetylcholine (ACh) receptor antagonist, on retinal ganglion cells (RGCs) remains unclear. After immersing the cornea
Qin Wang, Seema Banerjee, ChungHim So, ChunTing Qiu, YingHon Sze, Thomas Chuen Lam, Thomas Chuen Lam, Chi-Ho To, Chi-Ho To, Feng Pan, Feng Pan   +10 more
doaj   +1 more source

Varying Dose of Atropine in Slowing Myopia Progression in Children Over Different Follow-Up Periods by Meta-Analysis

Frontiers in Medicine, 2022
Purpose: To evaluate the efficacy and safety of atropine for slowing myopia progression and to investigate whether the treatment effect remains constant with continuing treatment.Method: Studies were retrieved from MEDLINE, EMBASE, and the Cochrane ...
Jiahe Gan, Jiahe Gan, Shi-Ming Li, Shi-Ming Li, Shanshan Wu, Kai Cao, Kai Cao, Dandan Ma, Dandan Ma, Xi He, Xi He, Ziyu Hua, Ziyu Hua, Meng-Tian Kang, Meng-Tian Kang, Shifei Wei, Shifei Wei, Weiling Bai, Weiling Bai, Ningli Wang, Ningli Wang   +20 more
doaj   +1 more source

Stability and Sterility of Extemporaneously Prepared 0.01% Atropine Ophthalmic Solution in Artificial Tears and Balanced Salt Solution

Siriraj Medical Journal, 2022
Objective: The aim of this study was to investigate the physicochemical and microbiological stability of extemporaneously prepared 0.01% atropine ophthalmic solution in unopened eyedropper and in simulated use condition.
Jureeporn Sri-in, Waraphorn Sisan, Phonphailin Kingkhangphloo, Pinpilai Jutasompakorn, Weerawadee Chandranipapongse, Somruedee Chatsiricharoenkul, Onchira Buranakan, Arpha Pornseth, Thammanoon Surachatkumtonekul   +8 more
doaj   +1 more source

0.05% atropine on control of myopia progression in Chinese school children: a randomized 3-year clinical trial [PDF]

International Journal of Ophthalmology, 2023
AIM: To evaluate the effect of 0.05% atropine on the control of myopia for 2y (phase I) and on spherical equivalent refraction (SER) progression for 1y (phase II) after its withdrawal in Chinese myopic children.
Qin Zhu, Guang-Yong Tang, Zhi-Juan Hua, Li-Ping Xue, Yuan Zhou, Jie-Ying Zhang, Ying-Ting Zhu, Xiao-Fan Zhang   +7 more
doaj   +1 more source

Hospital-prepared low-dose atropine eye drops for myopia progression control using atropine sulfate injection diluted in normal saline and lubricants

BMC Research Notes, 2022
Objective As low-dose atropine eye-drops for myopia progression control prepared in-house by diluting the commercial 0.1% atropine eye-drop with sterile water or normal saline has been a common practice whereas atropine injection is readily available and
Nuthida Wongwirawat, Nirachorn Kuchonthara, Sorrawit Boontanomwong, Krit Pongpirul   +3 more
doaj   +1 more source